TY - STD TI - Globocan 2012.http://globocan.iarc.fr/Default.aspx. UR - http://globocan.iarc.fr/Default.aspx ID - ref1 ER - TY - STD TI - Eurocare 2008. http://www.eurocare.it/AboutUs/tabid/54/Default.aspx. UR - http://www.eurocare.it/AboutUs/tabid/54/Default.aspx ID - ref2 ER - TY - STD TI - Expósito J. (coord.) Comprehensive Andalusia Cancer Plan 2007-2012. Consejería de Salud. 2007. ID - ref3 ER - TY - STD TI - Chamie K, William SB, Hu JC. Population-based assessment of determining treatments for prostate cancer. JAMA Oncol. 2015; doi:10.1001/jamaoncol2014.192. ID - ref4 ER - TY - BOOK AU - Heidenreich, A. AU - Bastian, P. J. AU - Bellmunt, J. AU - Bolla, M. AU - Joniau, S. AU - Mason, M. D. PY - 2013 DA - 2013// TI - Guidelines on prostate cancer PB - European Association of Urology (EAU) CY - Arnhem (The Netherlands) ID - Heidenreich2013 ER - TY - JOUR AU - Fowler, F. J. AU - Barry, M. J. AU - Lu-Yao, G. PY - 1996 DA - 1996// TI - Outcomes of external beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance epidemiology and end results areas JO - J Clin Oncol VL - 14 ID - Fowler1996 ER - TY - JOUR AU - Slotman, B. J. AU - Vos, P. H. PY - 2013 DA - 2013// TI - Planning of radiotherapy capacity and productivity JO - Radiother Oncol VL - 106 UR - https://doi.org/10.1016/j.radonc.2013.02.006 DO - 10.1016/j.radonc.2013.02.006 ID - Slotman2013 ER - TY - JOUR AU - Kilsdonk, M. J. AU - Dijk, B. A. AU - Otter, R. PY - 2014 DA - 2014// TI - Regional variation in breast cancer treatment in the Netherlands and the role of external peer review: a cohort study comprising 63,516 women JO - BMC Cancer VL - 14 UR - https://doi.org/10.1186/1471-2407-14-596 DO - 10.1186/1471-2407-14-596 ID - Kilsdonk2014 ER - TY - JOUR AU - Grau, C. AU - Defourny, N. AU - Malicki, J. PY - 2014 DA - 2014// TI - Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey JO - Radiother Oncol VL - 112 UR - https://doi.org/10.1016/j.radonc.2014.08.029 DO - 10.1016/j.radonc.2014.08.029 ID - Grau2014 ER - TY - JOUR AU - Tovar, I. AU - Expósito, J. AU - Jaén, J. PY - 2013 DA - 2013// TI - Underuse of radiotherapy in lung cancer has negative consequences for patients JO - J Thorac Oncol VL - 8 UR - https://doi.org/10.1097/JTO.0b013e3182745640 DO - 10.1097/JTO.0b013e3182745640 ID - Tovar2013 ER - TY - JOUR AU - Expósito, J. AU - Jaén, J. AU - Alonso, E. PY - 2012 DA - 2012// TI - Use of palliative radiotherapy in brain and bone metastases (VARA II study) JO - Radiat Oncol VL - 7 UR - https://doi.org/10.1186/1748-717X-7-131 DO - 10.1186/1748-717X-7-131 ID - Expósito2012 ER - TY - JOUR AU - Tovar, I. AU - Expósito, J. AU - Jaén, J. PY - 2014 DA - 2014// TI - Pattern of use of radiotherapy for lung cancer: a descriptive study JO - BMC Cancer VL - 14 UR - https://doi.org/10.1186/1471-2407-14-697 DO - 10.1186/1471-2407-14-697 ID - Tovar2014 ER - TY - STD TI - National Institute of Statistic, Spanish Health Ministry. http://www.ine.es. UR - http://www.ine.es/ ID - ref13 ER - TY - STD TI - Cózar JM. Registro Nacional de Ca de próstata 2010 en España. Acta Urológica Española. 2013: 37. doi:10.1016/j.acuro.2012.06.006. ID - ref14 ER - TY - STD TI - Situación del cáncer en España. Instituto Carlos III (Madrid) 2009. http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/epicancerjunio2009-revisado2.pdf. UR - http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/epicancerjunio2009-revisado2.pdf ID - ref15 ER - TY - JOUR AU - Tyldesley, S. AU - Delaney, G. AU - Foroudi, F. PY - 2011 DA - 2011// TI - Estimating the need for radiotherapy for patients with prostate, breast, and lung cancers: verification of model estimates of need with radiotherapy utilization data from British Columbia JO - Int J Radiat Oncol Biol Phys VL - 79 UR - https://doi.org/10.1016/j.ijrobp.2009.12.070 DO - 10.1016/j.ijrobp.2009.12.070 ID - Tyldesley2011 ER - TY - STD TI - Delanay GP, et al. Evidence-based estimates of demand for Radiotherapy. Clin Oncol. 2014; 1-7. doi.org/10.1016/j.clon.2014.10.005. ID - ref17 ER - TY - STD TI - Barton M, Jacob S, Shafiq J, et al. Review of optimal radiotherapy utilization rates. Ingham Institute. March 2013. http://inghaminstitute.org.au/sites/default/files/RTU_Review_Final_v3_02042013.pdf. UR - http://inghaminstitute.org.au/sites/default/files/RTU_Review_Final_v3_02042013.pdf ID - ref18 ER - TY - JOUR AU - Kerba, M. AU - Miao, Q. AU - Zhang- Salomons, J. AU - MacLillop, W. PY - 2010 DA - 2010// TI - Defining the need for prostate cancer radiotherapy in general population: a criterion based benchmarking approach JO - Clin Oncol VL - 22 UR - https://doi.org/10.1016/j.clon.2010.07.006 DO - 10.1016/j.clon.2010.07.006 ID - Kerba2010 ER - TY - JOUR AU - Bentzen, S. M. AU - Heeren, G. AU - Cottier, B. PY - 2005 DA - 2005// TI - Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS Project JO - Radiother Oncol VL - 75 UR - https://doi.org/10.1016/j.radonc.2004.12.007 DO - 10.1016/j.radonc.2004.12.007 ID - Bentzen2005 ER - TY - JOUR AU - Kerba, M. AU - Miao, Q. AU - Zhang-Salomons, J. PY - 2007 DA - 2007// TI - Defining the need for breast cancer radiotherapy in the general population: a criterion-based benchmarking approach JO - Clin Oncol (R Coll Radiol) VL - 19 UR - https://doi.org/10.1016/j.clon.2007.03.013 DO - 10.1016/j.clon.2007.03.013 ID - Kerba2007 ER - TY - JOUR AU - Jaén, J. AU - Alonso, E. AU - Expósito, J. AU - de las Peñas, M. D. AU - Cabrera, P. PY - 2007 DA - 2007// TI - Evidence-based estimation and radiotherapy utilization rate, in Andalusia JO - Clin Transl Oncol VL - 9 UR - https://doi.org/10.1007/s12094-007-0141-1 DO - 10.1007/s12094-007-0141-1 ID - Jaén2007 ER - TY - JOUR AU - Zelefsky, M. J. AU - Kollmeier, M. AU - Brett Cox, B. PY - 2012 DA - 2012// TI - Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer JO - Int J Radiat Oncol Biol Phys VL - 84 UR - https://doi.org/10.1016/j.ijrobp.2011.11.047 DO - 10.1016/j.ijrobp.2011.11.047 ID - Zelefsky2012 ER - TY - JOUR AU - Dunscombe, P. AU - Grau, C. AU - Defourny, N. AU - Malicki, J. PY - 2014 DA - 2014// TI - Guidelines for equipment and staffing of radiotherapy facilities in the Europe countries: Final results of the ESTRO.HERO survey JO - Radiother Oncol VL - 112 UR - https://doi.org/10.1016/j.radonc.2014.08.032 DO - 10.1016/j.radonc.2014.08.032 ID - Dunscombe2014 ER - TY - JOUR AU - Hegemann, N. S. AU - Guckenberger, M. AU - Belka, C. AU - Ganswindt, U. AU - Manapov, F. AU - Li, H. PY - 2014 DA - 2014// TI - Hypofractionated radiotherapy for prostate cancer JO - Radiat Oncol VL - 9 UR - https://doi.org/10.1186/s13014-014-0275-6 DO - 10.1186/s13014-014-0275-6 ID - Hegemann2014 ER - TY - JOUR AU - Nag, S. AU - Beber, D. AU - Friedland, J. PY - 1999 DA - 1999// TI - American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer JO - Int J Radiat Oncol Biol Phys VL - 44 UR - https://doi.org/10.1016/S0360-3016(99)00069-3 DO - 10.1016/S0360-3016(99)00069-3 ID - Nag1999 ER - TY - JOUR AU - Bill-Axelson, A. AU - Garmo, H. AU - Holmberg, L. PY - 2013 DA - 2013// TI - Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial JO - Eur Urol VL - 64 UR - https://doi.org/10.1016/j.eururo.2013.02.025 DO - 10.1016/j.eururo.2013.02.025 ID - Bill-Axelson2013 ER - TY - JOUR AU - López-Torrecilla, J. AU - Zapatero, A. AU - Herruzo, I. AU - Calvo, F. A. PY - 2014 DA - 2014// TI - Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer JO - Clin Trasl Oncol VL - 16 UR - https://doi.org/10.1007/s12094-013-1121-2 DO - 10.1007/s12094-013-1121-2 ID - López-Torrecilla2014 ER - TY - JOUR AU - Loon, J. AU - Grutters, J. AU - Macbeth, F. PY - 2013 DA - 2013// TI - Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it? JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(11)70379-5 DO - 10.1016/S1470-2045(11)70379-5 ID - Loon2013 ER - TY - JOUR AU - Sullivan, R. PY - 2011 DA - 2011// TI - Delivering affordable cancer care in high-income countries JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(11)70141-3 DO - 10.1016/S1470-2045(11)70141-3 ID - Sullivan2011 ER -